Royal DSM’s venture investment arm, DSM Venturing, has made an equity investment in skin microbiome company S-Biomedic NV. This investment completes S-Biomedic’s latest Series A financing round.   S-Biomedic is a Belgium based life sciences company pioneering a new approach to cosmetic and therapeutic potential of the skin microbiome.   This investment underlines DSM’s interest in the skin microbiome, an area it has identified as having significant growth potential. DSM already holds a stron...